Condensing naphthalene-2-sulfonylhydrazide with 9-ethyl-9H-carbazole-1-carbaldehyde starting materials resulting the formation of novel N'-((9-ethyl-9H-carbazol-1-yl)methylene)naphthalene-2-sulfonohydrazide Schiff base (S.B.) ligand with high yield and without having any unwanted side products. A wide range of physicochemical measurements, such as CHN-EA, UV-Vis., NMR, FT-IR, and ESI-MS were used to extensively investigate the structural properties of the desired S.B. ligand, the highest level of B3LYB/DFT also served to optimize the 3D structure of the S.B. ligand. Moreover, the experimental optical properties via the UV-Vis absorption measurements were compared to the theoretical DFT/TD-DFT study under identical conditions and using The DCM as solvent. Furthermore, to evaluate the prepared S.B. ligand as a future work drug for treating different types of infections, the LOX and COX anti-inflammatory computation capability was evaluated via the in silico molecular docking using the suitable enzymes. © 2024, University of Mohammed Premier Oujda Morocco

Title

Moroccan Journal of Chemistry

Publisher

University Mohammed Premier Oujda

Publisher Country

Morocco

Indexing

Scopus

Impact Factor

None

Publication Type

Online only

Volume

12

Year

2024

Pages

78-88